ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,203,256 | -7.0% | 39,143 | +9.0% | 0.01% | -28.6% |
| Q1 2023 | $1,294,270 | +182.8% | 35,922 | +210.2% | 0.01% | +250.0% |
| Q4 2022 | $457,721 | -76.5% | 11,582 | -76.1% | 0.00% | -77.8% |
| Q3 2022 | $1,950,000 | +8025.0% | 48,525 | +8266.4% | 0.01% | – |
| Q2 2022 | $24,000 | -89.3% | 580 | -89.9% | 0.00% | -100.0% |
| Q1 2022 | $224,000 | +622.6% | 5,759 | +644.1% | 0.00% | – |
| Q4 2021 | $31,000 | -99.4% | 774 | -99.4% | 0.00% | -100.0% |
| Q3 2021 | $4,881,000 | -57.7% | 135,049 | -52.1% | 0.01% | -52.0% |
| Q2 2021 | $11,550,000 | +5247.2% | 281,774 | +5598.2% | 0.02% | +2400.0% |
| Q1 2021 | $216,000 | -77.8% | 4,945 | -75.3% | 0.00% | -87.5% |
| Q2 2020 | $971,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |